History

Mediwish Co., Ltd. was established in Hefei, Anhui, China on 22 February 2011. The company's registered Chinese legal entity is 安徽美志斯工贸有限公司.

Packaging materials were among the company's original business activities, providing the foundation for Mediwish's later development in medical sterilization packaging and related sterile-processing products.

The company's brand identity also dates to this formative period. Chinese copyright records document the creation of MEDIWISH-related artwork on 23 February 2011, only one day after the company's establishment.

This early combination of packaging manufacturing and brand development formed the basis for the MEDIWISH product portfolio that would expand over the following years.

The development of the company's brand identity also dates to its earliest period. Chinese copyright records document that both the 美志斯 and MEDIWISH artworks were created on 23 February 2011.

In 2012, the company's early brand identity entered documented public use.

Chinese copyright records identify 12 March 2012 as the first-publication date of the 美志斯 artwork.

The same year, the company strengthened protection of its commercial identity through Chinese trademark registration No. 9604723 in Nice Class 10, with the original registration period beginning on 21 August 2012.

The trademark was subsequently renewed, extending its protection through 20 August 2032.

The international-facing MEDIWISH visual identity continued developing alongside the company's commercial activities.

Chinese copyright records identify 12 May 2013 as the first-publication date of the registered MEDIWISH artwork.

The record identifies 安徽美志斯工贸有限公司 as both the author and copyright holder, providing documented continuity between the company and the MEDIWISH visual identity.

From 2014, Mediwish expanded its product development into chemical indicators for sterilization, adding process-monitoring products to its established packaging activities.

This marked an important step in the company's development: Mediwish was no longer focused only on packaging, but increasingly on products supporting the broader sterilization-assurance workflow.

The monitoring portfolio subsequently expanded into related solutions such as indicator tapes and strips, Bowie-Dick test packs, Helix systems and process challenge devices (PCD).

These categories later became one of the principal areas of MEDIWISH specialization.

During 2016–2018, Mediwish expanded its product and manufacturing experience into selected disposable dental products and related medical consumables.

This development broadened the company's experience in professional healthcare consumables and added product categories used by dental clinics, distributors and medical professionals.

Selected dental and related consumable products remain part of the wider MEDIWISH portfolio today, alongside the company's primary strategic focus on sterile processing, sterilization monitoring and cleaning verification.

From approximately 2018, Mediwish began developing products for cleaning verification and cleaning-process monitoring.

This extended the company's role further upstream in the medical-device reprocessing workflow. Before instruments can be packaged and sterilized, the effectiveness of the cleaning process itself must be evaluated.

The category developed to include cleaning indicators, protein-residue testing, ultrasonic-cleaning monitoring, washer-disinfector cleaning-performance verification and related monitoring products.

Cleaning verification is now one of the principal areas connecting the MEDIWISH portfolio across cleaning, preparation, packaging and sterilization.

During the COVID-19 pandemic, Mediwish expanded production of disposable medical masks and related protective medical products in response to exceptional international demand.

Large-volume shipments were supplied to overseas markets at a time when global medical-product logistics and air-freight capacity were under extraordinary pressure.

Company archives document MEDIWISH mask shipments being prepared and loaded for international air transport, including shipments that used passenger-cabin capacity during the unusual logistics conditions of the pandemic.

This period demonstrated the company's ability to adapt production and international supply operations during a major global healthcare emergency.

In October 2021, the Copyright Protection Center of China formally registered the previously created MEDIWISH and 美志斯 artworks.

The registrations preserve the documented earlier history of both works. The 美志斯 artwork is recorded as created on 23 February 2011 and first published on 12 March 2012.

The MEDIWISH artwork is likewise recorded as created on 23 February 2011, with its first-publication date recorded as 12 May 2013.

Both registrations identify 安徽美志斯工贸有限公司 as the author and copyright holder. The 2021 registrations therefore formalized copyright records for brand artwork whose documented creation and publication predate the registrations by many years.

In 2022, two important elements of Mediwish's international development were formally documented: quality-management certification and European trademark protection.

Mediwish's quality management system was assessed and registered by NQA against ISO 13485:2016 for defined manufacturing and sales activities.

The European Union Intellectual Property Office also registered European Union Trade Mark No. 018603489 in Nice Classes 5, 10 and 16.

These developments strengthened both the quality-management framework behind MEDIWISH products and the formal protection of the brand in the European Union.

During 2023–2024, Mediwish continued expanding formal protection of the MEDIWISH brand across international markets, with trademark registrations in the United States, Australia, Japan, Indonesia and other jurisdictions.

In 2024, the company's registered Chinese legal entity, 安徽美志斯工贸有限公司, was recognized as a National High-Tech Enterprise of China (国家级高新技术企业). The published 2024 Anhui recognition list identifies the company in Hefei under High-Tech Enterprise Certificate No. GR202434002097.

Verify MEDIWISH in the published 2024 Anhui High-Tech Enterprise list

This recognition is not a self-declared marketing title or a commercial supplier award. It is granted under China's government-administered High-Tech Enterprise recognition framework following an application, expert review and formal recognition process. Applicants must meet defined requirements covering intellectual property, research and development, technical personnel, technological innovation, high-tech products or services and commercialization of technological achievements.

The official recognition criteria include requirements for R&D expenditure, technological personnel and revenue from qualifying high-tech products or services. Recognized enterprises must also demonstrate the required innovation capability and submit supporting corporate, intellectual-property, R&D and financial documentation. View the official recognition requirements from China's Ministry of Science and Technology .

For Mediwish, this recognition represents an important milestone in the company's development from its original packaging activities toward a more technology-driven manufacturer specializing in sterilization packaging, sterilization process monitoring, cleaning verification and related medical-product technologies.

Mediwish continued operating under its ISO 13485:2016 quality management system with ongoing audit and certification oversight.

The current NQA certificate, No. 131860, records the latest audit on 17 November 2025 and was reissued on 4 December 2025.

The certificate is valid through 30 November 2028 and covers defined manufacturing and sales activities across sterilization packaging, sterilization monitoring, cleaning verification and additional specified medical-product categories.

This continuing certification supports Mediwish's focus on manufacturing controls, documentation, product consistency and traceability within the applicable certified scope.

Today, Mediwish's principal strategic focus brings together the capabilities developed throughout the company's history: sterilization packaging, sterilization process monitoring, cleaning verification and related infection-control products.

The company serves healthcare organizations, distributors, importers and OEM/ODM partners with standard products, private-label programs, customized packaging, multilingual labelling and market-specific product configurations.

Rather than operating as a general medical marketplace, MEDIWISH is positioned around a connected cleaning, preparation, packaging, sterilization and monitoring workflow.

Learn more about Mediwish Co., Ltd. , the MEDIWISH brand and our official legal identity .